Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

SGSM3 Activators

SGSM3 Activators encompass a diverse array of chemical compounds that indirectly bolster the functional activity of SGSM3 through modulation of specific signaling pathways. Forskolin, IBMX, and 8-Bromo-cAMP all amplify intracellular cAMP levels, which can activate protein kinase A (PKA). PKA, in turn, is known to phosphorylate various substrates that may be involved in the signaling pathways that SGSM3 modulates, particularly those linked to intracellular trafficking and vesicle movement. Similarly, PMA, through activation of PKC, and Bisindolylmaleimide I, by its inhibition of PKC, may influence SGSM3 activity by modifying the phosphorylation status of proteins within SGSM3-related signaling pathways. This modulation potentially affects the intricate processes of membrane dynamics and cargo sorting in which SGSM3 is implicated. Moreover, Ionomycin and A23187, both acting as calcium ionophores, could lead to the activation of calcium-dependent proteins and enhance SGSM3 signaling capabilities by influencing pathways dependent on calcium signaling.

Furthermore, U0126 serves as an inhibitor for MEK1/2, altering the associated AKT and ERK signaling pathways. Epigallocatechin gallate (EGCG), with its protein kinase inhibitory properties, might recalibrate signaling pathways to favor those regulated by SGSM3, enhancing its role in cellular signaling networks. Sphingosine-1-phosphate activates its cognate receptors and could potentiate SGSM3's role in signaling pathways that oversee intracellular trafficking, a key aspect of SGSM3's functionality. Rolipram, by preventing phosphodiesterase 4 activity, also raises cAMP levels, thereby amplifying PKA activity which could have downstream effects on SGSM3's activity within its signaling milieu. Collectively, these activators operate through distinct but interrelated mechanisms, converging on the enhancement of SGSM3's activity within its native signaling pathways, thus bolstering the protein's intrinsic functional capacity without affecting its expression levels directly.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin increases intracellular cAMP, which in turn can activate PKA. PKA phosphorylation events can enhance the functional activity of SGSM3 by activating pathways SGSM3 is involved in, particularly those related to intracellular trafficking.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, leading to an increase in cAMP levels. Elevated cAMP could enhance SGSM3 activity by stimulating signaling cascades that SGSM3 modulates.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which can phosphorylate proteins within signaling pathways that SGSM3 is a part of, potentially enhancing its activity related to membrane dynamics.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, possibly leading to the activation of calcium-dependent proteins that interact with SGSM3, enhancing its signaling capabilities.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can modify the activity of proteins and signaling pathways associated with SGSM3, thus enhancing its functional role.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels, and subsequent PKA activation. This can enhance SGSM3 activity indirectly through PKA's role in signaling pathways that SGSM3 is involved in.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a known inhibitor of various protein kinases, which can alter multiple signaling pathways. This may lead to an indirect enhancement of SGSM3 activity by shifting the balance of signaling towards pathways that SGSM3 regulates.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, potentially enhancing SGSM3 activity by influencing signaling pathways that regulate intracellular trafficking, where SGSM3 is active.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I is a specific PKC inhibitor that can modulate PKC activity, potentially enhancing SGSM3 signaling pathways by affecting the phosphorylation status of proteins within those pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is a calcium ionophore similar to Ionomycin and can increase intracellular calcium, which can lead to activation of SGSM3 through calcium-dependent signaling pathways.